Back to results
US 8,709,718 B1Granted
Method of treating lung cancer
AssigneeMax-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
InventorsRoman K. Thomas, Martin L. Sos, Jonathan Weiss
Life of this patent
Estimating the term…
Abstract
A method of predicting a lung cancer patient's response to FGFR inhibitors is disclosed herein, particularly in patients with squamous cell lung cancer.
Claims13
A method of treating lung cancer in a human patient, the method comprising:
- detecting, in a lung cancer cell or tissue obtained from the patient, the presence of focal FGFR1 gene amplification;
- and
- administering a therapeutically effective amount of an FGFR1 inhibitor to the patient.
A method of treating lung cancer in a human patient, the method comprising:
- diagnosing the patient as having squamous cell lung cancer;
- detecting the presence of focal FGFR1 gene amplification in a squamous cell lung cancer cell or tissue obtained from the patient;
- and
- administering a therapeutically effective amount of an FGFR1 inhibitor to the patient.
1 more element
Dependencies are inferred from the claim text.